Literature DB >> 7561041

Down-regulation of CD8 on mature antigen-reactive T cells as a mechanism of peripheral tolerance.

L Zhang1, W Fung-Leung, R G Miller.   

Abstract

Previously we have shown that intravenous injection of male B6 lymphocytes containing CD8+ cells into B6 female anti-HY TCR transgenic mice results at 6 wk in the disappearance of the majority of male Ag-reactive T cells (TghighCD8+) from the periphery. Here we investigate the process in more detail. B6 female anti-HY TCR transgenic mice were intravenously injected with viable lymphocytes from male B6 normal, CD4-/-, CD8-/- or CD8-/- carrying a CD8 transgene lacking its cytoplasmic tail ("CD8 tail-less") mice. The fate of TghighCD8+ cells was followed in vivo. There was always a large (at least twofold) expansion of these cells in the periphery 4 days after encountering male Ag. Their subsequent fate differed, however, depending on whether or not the injected male lymphocytes contained normal CD8-expressing cells. If the injected male lymphocytes contained normal CD8 cells, at 6 wk there was a large drop in the number of TghighCD8+ cells associated with a rise in the number of TghighCD8- cells. If the injected male lymphocytes lacked CD8 cells or expressed only tail-less CD8, TghighCD8+ cell numbers returned to normal by 6 wk, while TghighCD8- cell numbers remained unchanged. The TghighCD8- cells, although carrying high levels of the male specific TCR, did not react to male Ag. In addition, their ability to respond in anti-CD3-induced activation, which does not require CD8 as a co-receptor, was significantly impaired. Our data suggest that down-regulation of CD8 on the Ag-reactive T cells accounts, at least partially, for the disappearance of HY-reactive T cells from the periphery. Further, some step in the process requires signaling through the cytoplasmic domain of CD8 on the injected Ag-bearing cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561041

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Molecular and cellular mechanisms of donor cell-induced tolerance.

Authors:  James F George; Leonik Ahumada; Ailing Lu
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  CTLs respond with activation and granule secretion when serving as targets for T-cell recognition.

Authors:  Oren Milstein; David Hagin; Assaf Lask; Shlomit Reich-Zeliger; Elias Shezen; Eran Ophir; Yaki Eidelstein; Ran Afik; Yaron E Antebi; Michael L Dustin; Yair Reisner
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

3.  Characterization of a novel and spontaneous mouse model of inflammatory arthritis.

Authors:  Iris A Adipue; Joel T Wilcox; Cody King; Carolyn A Y Rice; Katherine M Shaum; Cory M Suard; Elri ten Brink; Stephen D Miller; Eileen J McMahon
Journal:  Arthritis Res Ther       Date:  2011-07-12       Impact factor: 5.156

4.  Systemic autoimmunity and lymphoproliferation are associated with excess IL-7 and inhibited by IL-7Rα blockade.

Authors:  Rosana Gonzalez-Quintial; Brian R Lawson; John C Scatizzi; Joseph Craft; Dwight H Kono; Roberto Baccala; Argyrios N Theofilopoulos
Journal:  PLoS One       Date:  2011-11-10       Impact factor: 3.240

5.  Characterization of apoptosis-resistant antigen-specific T cells in vivo.

Authors:  L Zhang; R G Miller; J Zhang
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

6.  CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells.

Authors:  A J Adler; D W Marsh; G S Yochum; J L Guzzo; A Nigam; W G Nelson; D M Pardoll
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

7.  Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.

Authors:  Janna Krueger; Francois Santinon; Alexandra Kazanova; Mark E Issa; Bruno Larrivee; Richard Kremer; Catalin Milhalcioiu; Christopher E Rudd
Journal:  PLoS One       Date:  2021-06-28       Impact factor: 3.240

8.  Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation.

Authors:  Zhengguo Xiao; Matthew F Mescher; Stephen C Jameson
Journal:  J Exp Med       Date:  2007-10-22       Impact factor: 14.307

Review 9.  Co-Receptor CD8-Mediated Modulation of T-Cell Receptor Functional Sensitivity and Epitope Recognition Degeneracy.

Authors:  Barbara Szomolay; Tamsin Williams; Linda Wooldridge; Hugo Antonius van den Berg
Journal:  Front Immunol       Date:  2013-10-21       Impact factor: 7.561

10.  CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functions.

Authors:  Bruno Laugel; David A Price; Anita Milicic; Andrew K Sewell
Journal:  Eur J Immunol       Date:  2007-04       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.